Charles River Laboratories International (CRL) Operating Leases (2019 - 2025)

Charles River Laboratories International's Operating Leases history runs 7 years deep, the most recent figure standing at $434.0 million for Q4 2025.

• In Q4 2025, Operating Leases fell 10.28% year-over-year to $434.0 million; the TTM figure through Dec 2025 stood at $434.0 million (down 10.28% YoY), while the FY2025 annual figure was $434.0 million, down 10.28% from the prior year.
• Operating Leases was $434.0 million for Q4 2025 at Charles River Laboratories International, down from $443.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $483.8 million in Q4 2024 to a low of $173.0 million in Q1 2021.
• Historically, Operating Leases has averaged $383.2 million across 5 years, with a median of $418.1 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Operating Leases soared 84.07% in 2021, then slipped 10.28% in 2025.
• A 5-year view of Operating Leases shows it stood at $286.2 million in 2021, then surged by 52.41% to $436.3 million in 2022, then climbed by 8.68% to $474.1 million in 2023, then climbed by 2.03% to $483.8 million in 2024, then slipped by 10.28% to $434.0 million in 2025.
• The last three Operating Leases figures came in at $434.0 million (Q4 2025), $443.2 million (Q3 2025), and $453.7 million (Q2 2025), per Business Quant data.